Role of Antiplatelet and Anticoagulant Drugs in Stroke Patient – An Overview

Stroke remains a significant cause of morbidity and mortality worldwide.When someone has a stroke, it's crucial to find ways to prevent recurrent strokes and improve their health.Antiplatelet and anticoagulant therapies play important role in the prevention and treatment of ischemic and thromboembolic strokes.Antiplatelet drugs like aspirin and clopidogrel stop blood cells called platelets from sticking together, reducing the risk of recurrent ischemic events reducing the risk of recurrent ischemic events.Anticoagulants, such as warfarin and newer medicines like dabigatran, work differently by slowing down the blood's ability to clot, which can also lower the risk of strokes.This abstract explores the current understanding of the mechanisms, efficacy, and safety profiles of these pharmacotherapies in stroke management.However, selecting the most appropriate agent requires careful consideration of individual patient characteristics, including stroke subtype, comorbidities, and bleeding risk.Recent advancements, including the introduction of DOACs and the emergence of reversal agents, have expanded therapeutic options and improved the management of stroke patients.Though, challenges persist in optimizing the balance between efficacy and safety, underscoring the importance of personalized treatment approaches and ongoing research to refine clinical practice guidelines.Newer medicines have made treatment more effective, but doctors still need to be careful to balance the benefits of preventing strokes with the risks of side effects like bleeding.This summary gives a simple explanation of how these medicines work and why choosing the right one is important for helping stroke patients stay healthy.